Variant · Snv
CRISPLD2 NM_031476.4(CRISPLD2):c.1113-5A>C
CI-VAR-00132236Explore in graph →NM_031476.4:c.1113-5A>CClinVar 768803 rs7194957
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 768803 | Benign | criteria provided, multiple submitters, no conflicts | 2 | CRISPLD2-related disorder; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Sarcoma; Ovarian serous cystadenocarcinoma; Cervical cancer; Acute myeloid leukemia | germline | 4 | Jul 06, 2018 | clinvar |